These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28236088)

  • 1. [Cutaneous manifestations of Lyme disease : Pitfalls in the serological diagnostic workup].
    Glatz M; Müllegger RR
    Hautarzt; 2017 Apr; 68(4):329-339. PubMed ID: 28236088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is serological follow-up useful for patients with cutaneous Lyme borreliosis?
    Müllegger RR; Glatz M
    Curr Probl Dermatol; 2009; 37():178-182. PubMed ID: 19367102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin manifestations of lyme borreliosis: diagnosis and management.
    Müllegger RR; Glatz M
    Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.
    Hofmann H; Fingerle V; Hunfeld KP; Huppertz HI; Krause A; Rauer S; Ruf B;
    Ger Med Sci; 2017; 15():Doc14. PubMed ID: 28943834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatological manifestations of Lyme borreliosis.
    Mullegger RR
    Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?
    Jelić S; Filipović-Ljesković I
    Hematol Oncol; 1999 Sep; 17(3):107-16. PubMed ID: 10641031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status.
    Plörer A; Sepp N; Schmutzhard E; Krabichler S; Trobos S; Schauer G; Pahl C; Stöffler G; Fritsch P
    J Invest Dermatol; 1993 Feb; 100(2):103-9. PubMed ID: 8429231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis.
    Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):911-5. PubMed ID: 10666801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.
    Lager M; Dessau RB; Wilhelmsson P; Nyman D; Jensen GF; Matussek A; Lindgren PE; Henningsson AJ; ; Baqir H; Serrander L; Johansson M; Tjernberg I; Skarstein I; Ulvestad E; Grude N; Pedersen AB; Bredberg A; Veflingstad R; Wass L; Aleke J; Nordberg M; Nyberg C; Perander L; Bojesson C; Sjöberg E; Lorentzen ÅR; Eikeland R; Noraas S; Henriksson GA; Petrányi G
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1933-1945. PubMed ID: 31399914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The variable spectrum of cutaneous Lyme borreliosis. Diagnosis and therapy].
    Hofmann H
    Hautarzt; 2012 May; 63(5):381-9. PubMed ID: 22573314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
    Melby K; Steinbakk M; Jensenius M; Figenschau KJ
    NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.
    Ang CW; Brandenburg AH; van Burgel ND; Bijlmer HA; Herremans T; Stelma F; Lunel FV; van Dam AP;
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):222-8. PubMed ID: 26286381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory methods for the diagnosis of clinical forms of Lyme borreliosis].
    Assous MV
    Med Mal Infect; 2007; 37(7-8):487-95. PubMed ID: 17408896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serodiagnosis in dermatological diseases in Borrelia burgdorferi infections].
    Hofmann H; Meyer-König U
    Hautarzt; 1990 Aug; 41(8):424-31. PubMed ID: 2272826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.